Lupin signs MoU with Maharashtra govt to combat rising prevalence of CVD

Collaboration to enhance healthcare services, ensure timely diagnosis, and improve accessibility of healthcare services

Lupin, Boehringer Ingelheim ink $700-mn deal for anti-cancer drug
BS Web Team New Delhi
2 min read Last Updated : Jun 20 2023 | 4:33 PM IST
Lupin Ltd, on Tuesday, said that its corporate social responsibility (CSR) arm, Lupin Human Welfare and Research Foundation (LHWRF) has signed a Memorandum of Understanding (MoU) with the Maharashtra government to address the growing prevalence of Cardiovascular Diseases (CVD) and Chronic Obstructive Pulmonary Disease (COPD) in the Palghar district of Maharashtra.

In a regulatory filing, the company said, “The partnership aims to prioritise the diagnosis and treatment of these diseases while working to reducing their long-term prevalence.”

Collaboration to enhance healthcare services, ensure timely diagnosis, and improve accessibility of healthcare services, the company said in a statement.

Shares of Lupin Ltd, on Tuesday, rose marginally at Rs 830 on BSE.

“As a leading healthcare provider, Lupin has consistently championed improved accessibility to high-quality, cost-effective medicines for India’s marginalised and vulnerable communities,” said Nilesh Gupta, managing director, Lupin.

“Through our collaborative efforts with state governments, we aim to strengthen existing healthcare systems and programs, focus on awareness, and enhancing quality, accessibility, and utilisation of healthcare services,” he added.

“This collaboration is poised to significantly lower the prevalence of CVDs and COPD in Palghar’s selected blocks. Our unwavering dedication to tackling these health concerns with focused solutions will ensure a lasting impact on the community. By emphasising preventive measures, early detection, and comprehensive treatment options, we aim to alleviate the disease burden in the district, ultimately enhancing the overall health and well-being of the community,” said Dr. Nagnath Mudam, joint director (NCD), Directorate of Health Services, Maharashtra.

Tushara Shankar, Head of Corporate Social Responsibility, LHWRF, said, “Maharashtra has witnessed a notable surge in the prevalence of CVDs and COPD. Our partnership with the state government is focused on delivering disease management healthcare services, enabling supportive interventions, and prioritising preventive measures. By offering a comprehensive solution, our aim is to effectively combat these diseases and provide holistic care to the affected population.”
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Lupinpharma sctorsMaharashtra

First Published: Jun 20 2023 | 4:33 PM IST

Next Story